Impact of methylene blue and atorvastatin combination therapy on the apparition of cerebral malaria in a murine model

BACKGROUND: Proveblue®, a methylene blue dye that complies with European Pharmacopoeia and contains limited organic impurities and heavy metals of recognized toxicity, showed in vitro synergy against Plasmodium falciparum when combined with atorvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-Co...

Descripción completa

Detalles Bibliográficos
Autores principales: Dormoi, Jérome, Briolant, Sébastien, Desgrouas, Camille, Pradines, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637457/
https://www.ncbi.nlm.nih.gov/pubmed/23587099
http://dx.doi.org/10.1186/1475-2875-12-127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637457/
https://www.ncbi.nlm.nih.gov/pubmed/23587099
http://dx.doi.org/10.1186/1475-2875-12-127

Ejemplares similares